Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2000
11/09/2000WO2000066169A1 Pharmaceutical formulations
11/09/2000WO2000066160A1 Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same
11/09/2000WO2000066138A2 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
11/09/2000WO2000066137A1 Asialocytokines and treatment of liver disease
11/09/2000WO2000066135A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000WO2000066134A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000WO2000066130A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate
11/09/2000WO2000066126A2 Liposome compositions for improved drug retention
11/09/2000WO2000066116A2 Stable solid pharmaceutical compositions containing enalapril maleate
11/09/2000WO2000066107A2 Antimalarian agents for the treatment of asthma
11/09/2000WO2000066100A2 2r,4s-hydroxyitraconazole isomers
11/09/2000WO2000066099A2 Compositions comprising phosphodiesterase inhabitors for the treatment of sexual disfunction
11/09/2000WO2000066091A1 Amplification of folate-mediated targeting to tumor cells using polymers
11/09/2000WO2000066090A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000WO2000066089A1 Effervescent drug delivery system for oral administration
11/09/2000WO2000066088A1 Controlled release pharmaceutical preparation containing metamizole
11/09/2000WO2000066087A2 Emulsion-based processes for making microparticles
11/09/2000WO2000066086A1 Anti-inflammatory bioactive glass particulates
11/09/2000WO2000066085A1 A bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
11/09/2000WO2000066084A1 Aerosol formulations and devices for increasing libido in women via acute testosterone administration
11/09/2000WO2000066083A1 Folic acid supplement
11/09/2000WO2000066082A1 Anti-nausea compositions and methods
11/09/2000WO2000066074A1 Use of nanoscalar antimicrobial active ingredients in body deodorants
11/09/2000WO2000041504A3 Use of tertbutylhydroquinone for lowering blood cholesterol and/or blood triblycerides
11/09/2000WO2000040592A8 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
11/09/2000WO2000040218A3 Osmotic delivery system having space efficient piston
11/09/2000WO2000039095A3 Phenethyl-5-bromopyridylthiourea (pbt) and dihydroalkoxybenzyloxopyrimidine (dabo) derivatives exhibiting spermicidal activity
11/09/2000WO2000038672A3 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
11/09/2000WO2000035460A3 Pharmaceutical formulations
11/09/2000WO2000035437A3 Improving mental performance by increasing brain insulin sensitivity
11/09/2000WO2000035426A3 Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
11/09/2000WO2000035421A3 Integrative protein-dna cochleate formulations and methods for transforming cells
11/09/2000WO2000035419A3 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
11/09/2000WO2000031123A3 Retro-inversion peptides that target gastro-intestinal tract transport receptors and use thereof
11/09/2000WO2000028969A3 Methods for preparing coated drug particles and pharmaceutical formulations thereof
11/09/2000WO2000013662A9 Medicated chewing gum delivery system for nicotine
11/09/2000WO1999047678A9 Interferon alpha plasmids and delivery systems, and methods of making and using the same
11/09/2000DE19920840A1 Zubereitungen vom Emulsionstyp W/O mit erhöhtem Wassergehalt mit einem Gehalt an mittelpolaren Lipiden Preparations of emulsion type W / O with increased water content containing medium polar lipids
11/09/2000DE19920415A1 Metamizol enthaltende, kontrolliert freisetzende pharmazeutische Zusammensetzung Metamizole-containing controlled release pharmaceutical composition
11/09/2000DE19919751A1 Stabile, wäßrige Dispersionen und stabile, wasserdispergierbare Trockenpulver von Xanthophyllen, deren Herstellung und Verwendung Stable, aqueous dispersions and stable, water-dispersible dry powder of xanthophylls, their preparation and use
11/09/2000DE19917347A1 Verfahren und Vorrichtung zum trockenen Anbringen von Substanzen an inhalierbare pulverförmige Trägerstoffe Method and apparatus for applying dry substances on inhalable pulverulent carrier substances
11/09/2000CA2372947A1 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue
11/09/2000CA2372946A1 Asialocytokines and treatment of liver disease
11/09/2000CA2372841A1 Amplification of folate-mediated targeting to tumor cells using polymers
11/09/2000CA2372834A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles
11/09/2000CA2372229A1 Folic acid supplement
11/09/2000CA2372225A1 Anti-nausea compositions and methods
11/09/2000CA2372223A1 Use of phyllanthus for targeted stimulation of the immune system
11/09/2000CA2372220A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes
11/09/2000CA2371766A1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
11/09/2000CA2371757A1 Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents
11/09/2000CA2371483A1 Liposome compositions for improved drug retention
11/09/2000CA2371427A1 Parenteral pharmaceutical composition containing humanized monoclonal antibody fragment and stabilizing method thereof
11/09/2000CA2371231A1 Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate
11/09/2000CA2371034A1 Non-aqueous liquid shampoo composition
11/09/2000CA2369550A1 Methods and formulations for targeting infectious agents bearing host cell proteins
11/09/2000CA2369357A1 2r,4s-hydroxyitraconazole isomers
11/09/2000CA2368748A1 X-ray guided drug delivery
11/09/2000CA2365776A1 Method for treating abnormal cell proliferation in the brain
11/09/2000CA2365235A1 Cleaning compositions and tablets
11/08/2000EP1050304A1 Liquid ophthalmic preparations
11/08/2000EP1050301A1 Medicinal compositions
11/08/2000EP1050300A2 Selective antibacterial composition
11/08/2000EP1050299A1 Fluorometholone suspension eye drops
11/08/2000EP1049773A1 Inhibition of cytokine production
11/08/2000EP1049759A1 Novel polymerizable fatty acids, phospholipids and polymerized liposomes therefrom
11/08/2000EP1049711A1 Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
11/08/2000EP1049634A1 Methods and compositions for treating dermatoses
11/08/2000EP1049491A1 Gene therapy of tumors using non-viral delivery system
11/08/2000EP1049487A2 Method for treating acute intermittent porphyria (aip) and other porphyric diseases
11/08/2000EP1049483A1 Method for treating inflammatory diseases using heat shock proteins
11/08/2000EP1049480A1 Herbal anti-viral agent
11/08/2000EP1049470A1 Extended release tiagabine formulations with reduced side-effects
11/08/2000EP1049469A1 Biodegradable polymer matrices for sustained delivery of anesthetics
11/08/2000EP1049468A1 Utilization of powder preparations containing hydroxypyridones for treating leg ulcers and decubitus ulcers
11/08/2000EP1049467A1 Celecoxib compositions
11/08/2000EP1049461A2 Use of topical preparations of glyceryl trinitrate and lanolin for the treatment of erectile dysfunction
11/08/2000EP1049459A1 Oral liquid compositions
11/08/2000EP1049458A1 Lyophilization method for sustained-release preparations
11/08/2000EP1049457A1 Bioactive glass treatment of inflammation in skin conditions
11/08/2000EP1049454A2 Cosmetic and dermatological preparations containing higher electrolyte concentrations
11/08/2000EP1049453A2 Cosmetic or pharmaceutical preparations with a less sticky feel, containing glycerin esters of alfa-hydroxy carboxylic acids and satured fatty acids
11/08/2000EP1049452A2 Reduced lipid flowable cosmetic or dermatological preparations
11/08/2000EP1049424A1 A drug dosage form based on the teorell-meyer gradient
11/08/2000EP0814670B1 Method for production of chewing or bubble gum and chewing or bubble gum
11/08/2000EP0804155B1 Composition and method for enhancing transdermal electrotransport agent delivery
11/08/2000EP0789564A4 Polynucleotide compositions
11/08/2000EP0779806B1 Sustained release preparation containing metal salt of a peptide
11/08/2000EP0768870B1 Multiple encapsulation of oleophilic substances
11/08/2000EP0727959A4 Diagnostic uses of hydrazinoadenosines
11/08/2000EP0652766B1 Human growth hormone aqueous formulation
11/08/2000CN1272886A Polynucleotide encoding polypeptide having heparanase activity and expression of same in transduced cells
11/08/2000CN1272848A Diluting and disintegrating composition, method for obtaining same and use thereof
11/08/2000CN1272795A Water soluble dry compositions
11/08/2000CN1272793A Method of protecting against chronic infections
11/08/2000CN1272789A Pharmaceutical compositions for oral administration of molecular iodine
11/08/2000CN1272787A Sustained-release theophylline tablet
11/08/2000CN1272785A Micro-osmotic controlled drug delivery system
11/08/2000CN1272784A Medicinal compositions for application to mucosa
11/08/2000CN1272765A Stabilized mixtures of iodopropargyl compound and formaldehyde donor
1 ... 2439 2440 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 ... 2991